Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Neurosurgical Institute of Fudan University, Shanghai, China.
Curr Neuropharmacol. 2022;20(2):292-308. doi: 10.2174/1570159X19666210716114016.
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of neuroimaging techniques, various neuroimaging modalities with different advantages have deepened the understanding of MMD in terms of structural, functional, spatial, and temporal dimensions. At present, the main treatment for MMD focuses on neurological protection, cerebral blood flow reconstruction, and neurological rehabilitation, such as pharmacological treatment, surgical revascularization, and cognitive rehabilitation. In this review, we discuss recent progress in understanding the clinical features, in the neuroimaging evaluation and treatment of MMD.
烟雾病(MMD)是一种慢性脑血管病,其特征是颈内动脉虹吸段及大脑前、中动脉起始部狭窄或闭塞,脑底出现异常的小血管网。临床表现复杂。大量研究试图阐明 MMD 的临床特征,包括其流行病学、遗传特征和病理生理学。随着神经影像学技术的发展,各种具有不同优势的神经影像学方法从结构、功能、空间和时间等多个维度加深了对 MMD 的认识。目前,MMD 的主要治疗方法集中在神经保护、脑血流重建和神经康复方面,如药物治疗、血管重建术和认知康复等。本文就 MMD 的临床特征、神经影像学评估及治疗的最新进展进行综述。